Kewalramani Reshma sold VRTX

February 17, 2026 · Form 4 insider transaction

Kewalramani Reshma sold 6,554 shares of Vertex Pharmaceuticals Incorporated at $483.75 per share, a transaction worth $3.17M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
6,554
Price
$483.75
Total value
$3.17M
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after143,259
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR
Kewalramani Reshma sold VRTX: February 17, 2026 | Insider Trading Screener